Description:
Transiderm-Nitro is a transdermal patch designed for the controlled release of nitroglycerin over a 24-hour period. It provides a steady dose of nitroglycerin to help manage angina (chest pain) by improving blood flow to the heart. The patch is designed for convenience, allowing for a steady therapeutic effect without the need for multiple doses.
Ingredients:
-
Active Ingredient:
- Nitroglycerin 25 mg (delivers 5 mg over 24 hours)
-
Other Ingredients: [Include any excipients or inactive ingredients if known]
Usage Instructions:
-
Dosage: Apply one patch to the skin once every 24 hours.
-
Frequency: Use one patch per day.
-
Special Considerations:
- Apply the patch to a clean, dry, and hairless area of the skin, preferably on the chest or back.
- Rotate application sites to avoid skin irritation.
- Do not cut or alter the patch.
- Remove the patch after 24 hours and replace with a new one at a different site.
Benefits:
-
Controlled Release: Provides a consistent and controlled release of nitroglycerin over 24 hours, ensuring stable therapeutic levels.
-
Convenience: Simplifies dosing with a once-daily application, reducing the need for multiple doses.
-
Effective Angina Management: Helps to prevent and relieve angina by improving blood flow to the heart.
Precautions:
-
Contraindications: Avoid use if allergic to nitroglycerin or any other components of the patch.
-
Side Effects: Possible side effects include headaches, dizziness, skin irritation at the application site, or nausea. Consult a healthcare provider if severe reactions occur.
-
Interactions: May interact with other medications, particularly those for blood pressure or erectile dysfunction. Inform your healthcare provider of all medications being used.
Storage Instructions:
-
Temperature: Store at room temperature, between 20°C to 25°C (68°F to 77°F).
-
Humidity: Keep in a dry place, away from moisture.
-
Other Conditions: Protect from light and keep out of reach of children. Do not store in the bathroom or near heat sources.
Manufacturer:
Novartis Pharmaceuticals
